SLF CIL36590 Phase IIb COPD

Trial Profile

SLF CIL36590 Phase IIb COPD

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2016

At a glance

  • Drugs SLFCIL 36590 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Chiesi Farmaceutici SpA
  • Most Recent Events

    • 21 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top